Rewriting Biotech Discovery, Validation and Scale

17 Mar 2026
Auditorium
Main Stage
  • What does an AI-first R&D pipeline look like, and how are language models and predictive platforms using large biological datasets to surface new microbes, proteins, molecules, and genetic traits?
  • Which differentiated modes of action are showing the strongest commercial promise, and how are new biologicals and genetic innovations delivering measurable agronomic and economic value? 
  • How are early-stage discoveries validated with scientific rigor, and what is the emerging role of agentic AI in autonomously designing experiments, prioritizing targets, and accelerating validation?